AI Article Synopsis

  • The bacterium Verrucomicrobium spinosum has gained attention after its genome was sequenced, revealing key insights into its diaminopimelate/lysine biosynthesis via the DapL pathway.
  • Research confirmed the functionality of its dapL gene by demonstrating that the cloned enzyme can complement E. coli mutants deficient in diaminopimelate and lysine.
  • The study highlights the potential of targeting the DapL pathway in V. spinosum for antibiotic development, as it does not harm humans and can serve as a model for understanding gene essentiality in pathogens.

Article Abstract

The Gram-negative bacterium Verrucomicrobium spinosum has attracted interest in recent years following the sequencing and annotation of its genome. Comparative genomic analysis of V. spinosum using diaminopimelate/lysine metabolic genes from Chlamydia trachomatis suggests that V. spinosum employs the L,L-diaminopimelate aminotransferase (DapL) pathway for diaminopimelate/lysine biosynthesis. The open reading frame corresponding to the putative dapL ortholog was cloned and the recombinant enzyme was shown to possess L,L-diaminopimelate aminotransferase activity in vitro. In vivo analysis using functional complementation confirmed that the dapL ortholog was able to functionally complement an E. coli mutant that confers auxotrophy for diaminopimelate and lysine. In addition to its role in lysine biosynthesis, the intermediate diaminopimelate has an integral role in peptidoglycan biosynthesis. To this end, the UDP-N-acetylmuramoylalanyl-d-glutamyl-2,6-meso-diaminopimelate ligase ortholog was also identified, cloned, and was shown to possess meso-diaminopimelate ligase activity in vivo. The L,L-diaminopimelate aminotransferase pathway has been experimentally confirmed in several bacteria, some of which are deemed pathogenic to animals. Since animals, and particularly humans, lack the genetic machinery for the synthesis of diaminopimelate/lysine de novo, the enzymes involved in this pathway are attractive targets for development of antibiotics. Whether dapL is an essential gene in any bacteria is currently not known. V. spinosum is an excellent candidate to investigate the essentiality of dapL, since the bacterium employs the DapL pathway for lysine and cell wall biosynthesis, is non-pathogenic to humans, facile to grow, and can be genetically manipulated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390587PMC
http://dx.doi.org/10.3389/fmicb.2012.00183DOI Listing

Publication Analysis

Top Keywords

ll-diaminopimelate aminotransferase
16
diaminopimelate lysine
8
lysine biosynthesis
8
verrucomicrobium spinosum
8
udp-n-acetylmuramoylalanyl-d-glutamyl-26-meso-diaminopimelate ligase
8
dapl pathway
8
dapl ortholog
8
dapl
6
biosynthesis
5
pathway
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!